Annual progress reports
All eligible countries are invited to submit proposals for Gavi support.
Annual progress report Nigeria 2005
Annual progress report Nigeria 2003
Annual progress report Nigeria 2002
Annual progress report Nigeria 2001
Annual progress report Nigeria 2014
Annual progress report Nigeria 2013
Annual progress report Nigeria 2012
Annual progress report Nigeria 2011
Annual progress report Nigeria 2010
Annual progress report Nigeria 2009
Annual progress report Nigeria 2008
Annual progress report Nigeria 2007
Annual progress report Nigeria 2006
Annual progress report Nigeria 2004
Proposal for NVS-YF diagnostics support 2020 : Nigeria
Proposal for HSS (2019-2023): Nigeria
Proposal for CCEOP support (2019-2023): Nigeria
Proposal for NVS - Measles 2nd dose, Measles SIA, YF Campaign (2019-2020): Nigeria
Proposal for NVS - Measles Follow-up camp 2019 : Nigeria
Proposal for NVS - measles follow-up campaign (2017-2020) :Nigeria
Proposal for MenA Routine Support 2016: Nigeria
Proposal for HSS Support (2019-2023): NIgeria
Proposal for NVS - Measles SIA support: Nigeria(2)
Proposal for NVS - IPV support: Nigeria
Proposal for MenA support: Nigeria
Proposal for NVS - Measles SIA support: Nigeria
Proposal for NVS - YF campaign support: Nigeria
Proposal for NVS - PCV - 2nd phase support: Nigeria
Proposal for NVS - PCV support: Nigeria
Proposal for NVS - Penta support: Nigeria
Proposal for NVS- MenA campaign (2011 - 2013): Nigeria
Proposal for ISS support: Nigeria
Proposal for HSS support: Nigeria
Proposal for ISS support: Nigeria (2001)
Comprehensive multi-year plans, Financial sustainability plans, National Immunisation Strategy
The comprehensive multi-year plan (cMYP) is a single plan which consolidates several immunisation activities. It is a key planning and management tool for national immunisation programmes. It addresses global, national, and subnational immunisation objectives and strategies, and evaluates the costs and financing of the programme in line with the WHO-UNICEF Global Immunization Vision and Strategy 2006-2015. Gavi requires countries to submit a cMYP along with the standard proposal form when applying for Gavi support (ISS, INS, and NVS). In 2006, over 50 countries had developed cMYPs using the WHO-UNICEF cMYP guidelines and costing tool.
The cMYP replaces the financial sustainability plan (FSP), used to assess the funding challenges of a country's national immunisation programme within the broader health financing context and to describe the government’s approach to mobilising and effectively using resources to support medium- and long-term immunisation objectives.
Country co-financing information sheet
The country-specific co-financing sheets provide up-to-date information on countries’ eligibility status, co-financing fulfilment and requirements. They also give a summary of government health expenditure, including immunisation financing.
Specifically, the sheets provide a history of the Gavi-supported vaccines introduced per country, the country’s co-financing payments to date and its co-financing requirements for the current year. In case the country has defaulted on its co-financing requirements, there is an overview of the co-financing arrears of the previous year. Finally, the sheets provide co-financing projections for the next five years based on our latest forecasts.
The information sheets are updated at least twice per year to account for new information on countries’ co-financing fulfilment (in the first quarter) and eligibility status (in the third quarter).
Co-financing information sheet Nigeria
Data quality audit
The DQA has been developed by WHO to help evaluate the quality of countries' health information systems and to verify the accuracy of reported data. Read more.
Decision Letters and Partnerships Agreement
The Decision Letter or Partnership Framework Agreement provides a summary of the details of the new approval or continuation of a Gavi window of support, following the independent review of a new application or annual progress report submitted by a country.
Decision Letter PENTA Nigeria 2021
Decision Letter PCV R Nigeria 2021
Decision Letter M R 1&2 Nigeria 2021
Decision Letter MENA R Nigeria 2021
Decision Letter IPV R Nigeria 2021
Decision Letter PCV R Nigeria 2020
Decision Letter M R 1&2 Nigeria 2020
Decision Letter IPV Nigeria 2020
Decision Letter PENTA R Nigeria 2020
Decision Letter MENA R Nigeria 2020
Decision Letter YF Nigeria 2020
Decision Letter MENA Nigeria 2019
Decision Letter IPV Nigeria 2019
Decision Letter PENTA R Nigeria 2019
Decision Letter PCV Nigeria 2019
Decision Letter NVS Nigeria 2016
Decision Letter NVS Nigeria 2015
Decision Letter NVS Nigeria 2014(4)
Decision Letter Nigeria ISD 2019
Decision Letter NVS Nigeria 2014(2)
Decision Letter Nigeria Measles 2019
Decision Letter NVS Nigeria 2014
Decision Letter Nigeria YF 2019
Decision Letter NVS Nigeria 2014(3)
Decision Letter Nigeria Injection Safety Devices 2018
Partnership Framework Agreement Nigeria
Decision Letter Nigeria PCV Switch 2018
Decision letter NVS Nigeria 2013(3)
Decision Letter YF Campaign 2018
Decision letter NVS Nigeria 2013(2)
Decision Lettre Devices Nigeria 2017 (2)
Decision letter NVS Nigeria 2013
Decision Lettre NVS Nigeria 2017 (2)
Decision letter NVS Nigeria 2012
Decision Lettre NVS Nigeria 2017 (3)
Decision Lettre NVS Nigeria 2017 (4)
Decision Letter Devices Nigeria 2017
Decision Letter NVS Nigeria 2017
Decision Letter NVS and Devices Nigeria 2016
The HSS evaluation team visited several countries (in depth country studies) and conducted a number of country desk reviews (Country desk studies).
HSS evaluation Nigeria
COVAX Technical Assistance Plans
In September 2020, the Gavi Board approved resources from core funding to focus on urgent technical assistance (TA) needs for 92 AMC economies, for the planning and preparation for the introduction of the COVID-19 vaccine. The plan includes sets of activities, milestones and budget for a given year.
COVAX Technical Assistance Plan Nigeria 2021
Targeted country assistance plans
Targeted country assistance (TCA) are resources provided to in-country partners under Gavi’s partners’ engagement framework (PEF). A country’s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.
The joint appraisal report and Multi-Stakeholder Dialogue
The joint appraisal is an in-country, multi-stakeholder review of the implementation progress and performance of Gavi's vaccine and cash grant support to the country, and of its contribution to improved immunisation outcomes. The outcome of the appraisal is the completed "joint appraisal report" that captures Gavi grant performance as well as implementation challenges. The joint appraisal report informs discussions with national coordination mechanisms on areas where greater national investments and efforts, as well as technical support, are needed.
In 2020/2021, as a result of the COVID-19 pandemic, Multi-stakeholder dialogue (MSD) documents temporarily replaced the traditional Joint Appraisal to ensure that Gavi’s continuing support to the EPI programme be aligned with realities at country level.